{"id":686254,"date":"2024-01-30T18:14:02","date_gmt":"2024-01-30T18:14:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=686254"},"modified":"2024-01-30T18:14:02","modified_gmt":"2024-01-30T18:14:02","slug":"cystatin-c-assay-market-trends-scope-growth-size-technology-customization-available-for-forecast-2028","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/cystatin-c-assay-market-trends-scope-growth-size-technology-customization-available-for-forecast-2028_686254.html","title":{"rendered":"Cystatin C Assay Market Trends, Scope, growth, Size, Technology, &#038; Customization Available for Forecast 2028"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1706593192.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Cystatin C Assay Market Trends, Scope, growth, Size, Technology, &amp; Customization Available for Forecast 2028\" src=\"https:\/\/www.abnewswire.com\/uploads\/1706593192.jpeg\" alt=\"Cystatin C Assay Market Trends, Scope, growth, Size, Technology, &amp; Customization Available for Forecast 2028\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>China accounted for the largest share of the Asian cystatin C assay market. The large share of China can be attributed to the government efforts to increase awareness about the early detection of diseases and regular health check-ups; rising healthcare expenditure; the increasing number of hospitals and clinical diagnostic laboratories in India and China; and strengthening research base for diagnostic procedures across India, China, and Japan, rising cases of CKD.<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Browse 215 market data Tables and 42 Figures spread through 271 Pages and in-depth TOC on &#8220;Cystatin C Assay Market by Product (Analyzers, Kits, Reagents), Method (ELISA, PETIA, IFA, CLIA, PENIA), Application (Diagnostics, Research), Sample Type (Blood, Urine), End User (Hospitals, Clinical Laboratories), Region- Global Forecast to 2028<\/div>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/cystatin-c-assay-market-186075328.html?utm_source=ABnewswire&amp;utm_campaign=Paid&amp;utm_content=Referral\">Cystatin C Assay Market<\/a> in terms of revenue was estimated to be worth $377 million in 2023 and is poised to reach $540 million by 2028, growing at a CAGR of 7.5% from 2023 to 2028 according to a new report by MarketsandMarkets&trade;. The growth of this market is majorly driven by growing number of old age population and rising number of kidney diseases. However, high development costs of cystatin C assay may challenge the growth of this market.<\/p>\n<p style=\"text-align: justify;\"><strong>Download an Illustrative overview: <\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=186075328&amp;utm_source=ABnewswire&amp;utm_campaign=Paid&amp;utm_content=Referral\"><strong>https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=186075328<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">The Cystitis C test industry is balanced for critical development within the close future, driven by a rising request for exact and dependable biomarkers in healthcare. Cystitis C, a promising marker of kidney work, is picking up noticeable quality as an elective to conventional creatinine-based estimations. With a maturing populace, the expanding predominance of incessant kidney infections, and a developing accentuation on early illness discovery, the Cystitis C measure industry is anticipated to grow quickly.<\/p>\n<p style=\"text-align: justify;\"><strong>Browse in-depth TOC on &#8220;Cystatin C Assay Market&#8221;<\/strong><\/p>\n<p style=\"text-align: justify;\">215 &#8211; Tables<\/p>\n<p style=\"text-align: justify;\">42 &#8211; Figures<\/p>\n<p style=\"text-align: justify;\">271 &ndash; Pages<\/p>\n<p style=\"text-align: justify;\"><strong>Key Market Players of Cystatin C Assay Industry:<\/strong><\/p>\n<p style=\"text-align: justify;\">The significant players in the cystatin C assay are Siemens Healthcare GmbH (Germany), Thermo Fisher Scientific Inc. (US), Abbott (US), Roche Diagnostics Limited. (Switzerland), and Bio-Techne (US), Randox Laboratories Ltd. (UK), DiaSys Diagnostic Systems GmbH (Germany), and Eurolyser Diagnostica GmbH (Austria)<\/p>\n<p style=\"text-align: justify;\"><strong>Request Sample Pages: <\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=186075328&amp;utm_source=ABnewswire&amp;utm_campaign=Paid&amp;utm_content=Referral\"><strong>https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=186075328<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\"><strong>Cystatin C Assay Market Dynamics:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Drivers:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Rising prevalence of kidney diseases<\/li>\n<li>Growing geriatric population<\/li>\n<li>Recent advancements in chemiluminescence immunoassay technologies<\/li>\n<li>Growth in biotechnology and biopharmaceutical industries<\/li>\n<li>Increasing adoption of POC testing<\/li>\n<li>Supportive government policies<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Restraints:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Stringent requirements for approval of cystatin C assay instruments and consumables<\/li>\n<li>High development costs of cystatin C assays<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Opportunities:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Growth opportunities in emerging economies<\/li>\n<li>Importance of companion diagnostics<\/li>\n<li>Development of condition-specific biomarkers and tests<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Challenge:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Dearth of skilled professionals<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Segmentation by product and service<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Analyzers<\/li>\n<li>Kits<\/li>\n<li>Reagents<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Segmentation by application<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Diagnostics<\/li>\n<li>Research<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Segmentation by end user<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Hospitals<\/li>\n<li>Clinical Laboratories<\/li>\n<li>Pharmaceutical and Biotechnology Companies &amp; CROs &amp; Academic research institutes<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Regional segmentation<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>North America holds largest share<\/li>\n<li>Asia Pacific fastest growing region<\/li>\n<li>Europe second largest segment<\/li>\n<li>Latin America and Middle East &amp; Africa emerging markets<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Regional market breakdown<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>North America largest share due to high healthcare spending, developed infrastructure<\/li>\n<li>Asia Pacific fastest growth from increasing healthcare access and aging populations<\/li>\n<li>Europe also major market but growing at slower pace than APAC<\/li>\n<li>Latin America and Middle East &amp; Africa smaller markets but seeing growth<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><strong>Get 10% Free Customization on this Report: <\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/requestCustomizationNew.asp?id=186075328&amp;utm_source=ABnewswire&amp;utm_campaign=Paid&amp;utm_content=Referral\"><strong>https:\/\/www.marketsandmarkets.com\/requestCustomizationNew.asp?id=186075328<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\"><strong>About MarketsandMarkets&trade;:<\/strong><\/p>\n<p style=\"text-align: justify;\">MarketsandMarkets&trade; has been recognized as one of&nbsp;<strong>America&#8217;s best management consulting firms by Forbes<\/strong>, as per their recent report.<\/p>\n<p style=\"text-align: justify;\">MarketsandMarkets&trade; is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.<\/p>\n<p style=\"text-align: justify;\">Earlier this year, we made a formal transformation into one of America&#8217;s best management consulting firms as per a survey conducted by Forbes.<\/p>\n<p style=\"text-align: justify;\">The B2B economy is witnessing the emergence of&nbsp;$25 trillion&nbsp;of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this&nbsp;$25 trillion&nbsp;opportunity through our service lines &#8211; TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.<\/p>\n<p style=\"text-align: justify;\">Built on the &#8216;GIVE Growth&#8217; principle, we work with several Forbes Global 2000 B2B companies &#8211; helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore&trade; (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_17712.html\" rel=\"nofollow\">MarketsandMarkets\u2122 Research Private Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Mr. Aashish Mehra<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=cystatin-c-assay-market-trends-scope-growth-size-technology-customization-available-for-forecast-2028\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>630 Dundee Road  Suite 430<br \/><strong>City:<\/strong> Northbrook<br \/><strong>State:<\/strong> IL 60062<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/cystatin-c-assay-market-186075328.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/cystatin-c-assay-market-186075328.html<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/cystatin-c-assay-market-186075328.html\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=cystatin-c-assay-market-trends-scope-growth-size-technology-customization-available-for-forecast-2028\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China accounted for the largest share of the Asian cystatin C assay market. The large share of China can be attributed to the government efforts to increase awareness about the early detection of diseases and regular health check-ups; rising healthcare &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/cystatin-c-assay-market-trends-scope-growth-size-technology-customization-available-for-forecast-2028_686254.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,403,404,416],"tags":[],"class_list":["post-686254","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-UK","category-US","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/686254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=686254"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/686254\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=686254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=686254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=686254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}